Authors
Loading...
Evaluation of PlasmaSeq reveals 71% actionable insights in multiple myeloma samples, indicating benefits over traditional FISH.
Yee et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: